MP
Marla Persky (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $120K of XERS (15,500 sh × $7.72, as filed), executed Sep 11 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$120K
shares × price, as filed
Last traded
Sep 11 2025
Filed Sep 12 2025
Median ADV $16.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $120K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
XERS
Xeris Biopharma Holdings, Inc.
XERS · 0 buys · 1 sell
1 filing
Recent filings
XERSSALE
Xeris Biopharma Holdings, Inc.
View filing →
$120K15,500 sh × $7.72
Exec Sep 11 2025
Filed Sep 12 2025 · 5:30 PM ET